{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:54:08Z","timestamp":1768535648330,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CreativeLab ASD, Livorno, Italy"},{"name":"FIRM Onlus, Cremona, Italy"},{"DOI":"10.13039\/501100007343","name":"Universit\u00e0 degli Studi di Brescia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Brain metastases rarely complicate the natural history of patients with adrenocortical carcinoma (ACC). No information is available regarding the life expectancy and efficacy of treatments in ACC patients with brain involvement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A pooled analysis was performed by searching on PubMed and using the keywords: \u201cbrain metastases in adrenocortical carcinoma\u201d, and \u201cleptomeningeal metastases in adrenocortical carcinoma\u201d. Four patients diagnosed at Spedali Civili Hospital in Brescia were added to the analysis. Data concerning demographic, disease characteristics, adopted treatments and patient prognosis were collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 27 patients (18 adults and 9 children) were included in this study, 22 of them had an adequate follow-up. Brain metastases occurred late in the natural history of adult patients but not in that of children. Surgery plus\/minus radiation therapy was the treatment of choice. Adult patients with brain metastases had a poor prognosis with a median progression-free survival (PFS) and overall survival (OS) of 2 and 7\u00a0months, respectively. Median PFS and OS were not attained in children.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Brain metastases in ACC patients are rare and are associated with poor prognosis, particularly in adults. Surgery plus\/minus radiotherapy is the only therapeutic approach that can offer patients a chance to obtain durable local disease control.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-023-02140-1","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T11:59:54Z","timestamp":1687607994000},"page":"223-234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis"],"prefix":"10.1007","volume":"47","author":[{"given":"A.","family":"Turla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Cremaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zamparini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"De Maria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Abate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tamburello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sigala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Fontanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cosentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3956-0043","authenticated-orcid":false,"given":"A.","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"key":"2140_CR1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht M, Dekkers OM, Else T, Baudin E, Berruti A, de Krijger RR, Haak HR, Mihai R, Assie G, Terzolo M (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179:G1\u2013G46. https:\/\/doi.org\/10.1530\/EJE-18-0608","journal-title":"Eur J Endocrinol"},{"key":"2140_CR2","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","volume":"31","author":"M Fassnacht","year":"2020","unstructured":"Fassnacht M, Assie G, Baudin E, Eisenhofer G, de la Fouchardiere C, Haak HR, de Krijger R, Porpiglia F, Terzolo M, Berruti A (2020) Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO\u2013EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31:1476\u20131490. https:\/\/doi.org\/10.1016\/j.annonc.2020.08.2099","journal-title":"Ann Oncol"},{"key":"2140_CR3","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1210\/jc.2016-2894","volume":"102","author":"A Berruti","year":"2017","unstructured":"Berruti A, Grisanti S, Pulzer A, Claps M, Daffara F, Loli P, Mannelli M, Boscaro M, Arvat E, Tiberio G, Hahner S, Zaggia B, Porpiglia F, Volante M, Fassnacht M, Terzolo M (2017) Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma. J Clin Endocrinol Metab 102:1358\u20131365. https:\/\/doi.org\/10.1210\/jc.2016-2894","journal-title":"J Clin Endocrinol Metab"},{"key":"2140_CR4","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/14656566.2022.2106128","volume":"23","author":"V Cremaschi","year":"2022","unstructured":"Cremaschi V, Abate A, Cosentini D, Grisanti S, Rossini E, Lagan\u00e0 M, Tamburello M, Turla A, Sigala S, Berruti A (2022) Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? Expert Opin Pharmacother 23:1413\u20131424. https:\/\/doi.org\/10.1080\/14656566.2022.2106128","journal-title":"Expert Opin Pharmacother"},{"key":"2140_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1080\/14737140.2018.1510325","volume":"18","author":"S Puglisi","year":"2018","unstructured":"Puglisi S, Perotti P, Cosentini D, Roca E, Basile V, Berruti A, Terzolo M (2018) Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. Expert Rev Anticancer Ther 18:1125\u20131133. https:\/\/doi.org\/10.1080\/14737140.2018.1510325","journal-title":"Expert Rev Anticancer Ther"},{"key":"2140_CR6","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","volume":"366","author":"M Fassnacht","year":"2012","unstructured":"Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardi\u00e8re C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, M\u00fcller H-H, Skogseid B (2012) Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med 366:2189\u20132197. https:\/\/doi.org\/10.1056\/NEJMoa1200966","journal-title":"N Engl J Med"},{"key":"2140_CR7","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/cancers12040941","volume":"12","author":"M Lagan\u00e0","year":"2020","unstructured":"Lagan\u00e0 M, Grisanti S, Cosentini D, Ferrari VD, Lazzari B, Ambrosini R, Sardini C, Dalla Volta A, Palumbo C, Poliani PL, Terzolo M, Sigala S, Tiberio GAM, Berruti A (2020) Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: the brescia experience. Cancers (Basel) 12:941. https:\/\/doi.org\/10.3390\/cancers12040941","journal-title":"Cancers (Basel)"},{"key":"2140_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12020-021-02874-z","volume":"74","author":"S Grisanti","year":"2021","unstructured":"Grisanti S, Cosentini D, Lagan\u00e0 M, Turla A, Berruti A (2021) Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? Endocrine 74:475\u2013477. https:\/\/doi.org\/10.1007\/s12020-021-02874-z","journal-title":"Endocrine"},{"key":"2140_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0094-0143(05)70089-6","volume":"27","author":"LS Liou","year":"2000","unstructured":"Liou LS, Kay R (2000) Adrenocortical carcinoma in children. Review and recent innovations. Urol Clin N Am 27:403\u2013421. https:\/\/doi.org\/10.1016\/S0094-0143(05)70089-6","journal-title":"Urol Clin N Am"},{"key":"2140_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/cncr.24030","volume":"115","author":"M Fassnacht","year":"2009","unstructured":"Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller H-H, Hahner S, Allolio B (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma. Cancer 115:243\u2013250. https:\/\/doi.org\/10.1002\/cncr.24030","journal-title":"Cancer"},{"key":"2140_CR11","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","volume":"26","author":"R Lib\u00e9","year":"2015","unstructured":"Lib\u00e9 R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O, Bala M, Tabarin A, Beuschlein F, Vezzosi D, Deutschbein T, Borson-Chazot F, Hermsen I, Stell A, Fottner C, Leboulleux S, Hahner S, Mannelli M, Berruti A, Haak H, Terzolo M, Fassnacht M, Baudin E (2015) Prognostic factors in stage III\u2013IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann Oncol 26:2119\u20132125. https:\/\/doi.org\/10.1093\/annonc\/mdv329","journal-title":"Ann Oncol"},{"key":"2140_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2014-3182","volume":"100","author":"F Beuschlein","year":"2015","unstructured":"Beuschlein F, Weigel J, Saeger W, Kroiss M, Wild V, Daffara F, Lib\u00e9 R, Ardito A, al Ghuzlan A, Quinkler M, O\u00dfwald A, Ronchi CL, de Krijger R, Feelders RA, Waldmann J, Willenberg HS, Deutschbein T, Stell A, Reincke M, Papotti M, Baudin E, Tissier F, Haak HR, Loli P, Terzolo M, Allolio B, M\u00fcller H-H, Fassnacht M (2015) Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab 100:841\u2013849. https:\/\/doi.org\/10.1210\/jc.2014-3182","journal-title":"J Clin Endocrinol Metab"},{"key":"2140_CR13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","volume":"65","author":"A Berruti","year":"2014","unstructured":"Berruti A, Fassnacht M, Haak H, Else T, Baudin E, Sperone P, Kroiss M, Kerkhofs T, Williams AR, Ardito A, Leboulleux S, Volante M, Deutschbein T, Feelders R, Ronchi C, Grisanti S, Gelderblom H, Porpiglia F, Papotti M, Hammer GD, Allolio B, Terzolo M (2014) Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. Eur Urol 65:832\u2013838. https:\/\/doi.org\/10.1016\/j.eururo.2013.11.006","journal-title":"Eur Urol"},{"key":"2140_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/jcp.2007.050625","volume":"61","author":"M Volante","year":"2008","unstructured":"Volante M, Buttigliero C, Greco E, Berruti A, Papotti M (2008) Pathological and molecular features of adrenocortical carcinoma: an update. J Clin Pathol 61:787\u2013793. https:\/\/doi.org\/10.1136\/jcp.2007.050625","journal-title":"J Clin Pathol"},{"key":"2140_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1530\/EJE-21-0510","volume":"186","author":"YS Elhassan","year":"2022","unstructured":"Elhassan YS, Altieri B, Berhane S, Cosentini D, Calabrese A, Haissaguerre M, Kastelan D, Fragoso MCBv, Bertherat J, al Ghuzlan A, Haak H, Boudina M, Canu L, Loli P, Sherlock M, Kimpel O, Lagan\u00e0 M, Sitch AJ, Kroiss M, Arlt W, Terzolo M, Berruti A, Deeks JJ, Lib\u00e9 R, Fassnacht M, Ronchi CL (2022) S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. Eur J Endocrinol 186:25\u201336. https:\/\/doi.org\/10.1530\/EJE-21-0510","journal-title":"Eur J Endocrinol"},{"key":"2140_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1530\/EJE-22-0173","volume":"187","author":"M Riedmeier","year":"2022","unstructured":"Riedmeier M, Decarolis B, Haubitz I, Reibetanz J, Wiegering A, H\u00e4rtel C, Schlegel P-G, Fassnacht M, Wiegering V (2022) Assessment of prognostic factors in pediatric adrenocortical tumors: a systematic review and evaluation of a modified S-GRAS score. Eur J Endocrinol 187:751\u2013763. https:\/\/doi.org\/10.1530\/EJE-22-0173","journal-title":"Eur J Endocrinol"},{"key":"2140_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/EJE-19-0026","volume":"180","author":"A Berruti","year":"2019","unstructured":"Berruti A, Lib\u00e8 R, Lagan\u00e0 M, Ettaieb H, Sukkari MA, Bertherat J, Feelders RA, Grisanti S, Cartry J, Mazziotti G, Sigala S, Baudin E, Haak H, Habra MA, Terzolo M (2019) Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study. Eur J Endocrinol 180:311\u2013320. https:\/\/doi.org\/10.1530\/EJE-19-0026","journal-title":"Eur J Endocrinol"},{"key":"2140_CR18","doi-asserted-by":"publisher","first-page":"100422","DOI":"10.1016\/j.esmoop.2022.100422","volume":"7","author":"M Lagan\u00e0","year":"2022","unstructured":"Lagan\u00e0 M, Grisanti S, Ambrosini R, Cosentini D, Abate A, Zamparini M, Ferrari VD, Gianoncelli A, Turla A, Canu L, Terzolo M, Tiberio GAM, Sigala S, Berruti A (2022) Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma. ESMO Open 7:100422. https:\/\/doi.org\/10.1016\/j.esmoop.2022.100422","journal-title":"ESMO Open"},{"key":"2140_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa017","author":"AR Schreiber","year":"2020","unstructured":"Schreiber AR, Kar A, Goodspeed AE, Pozdeyev N, Somerset H, Raeburn CD, Tan A-C, Leong S, Wierman ME, Kiseljak-Vassiliades K (2020) Leptomeningeal metastasis from adrenocortical carcinoma: a case report. J Endocr Soc. https:\/\/doi.org\/10.1210\/jendso\/bvaa017","journal-title":"J Endocr Soc"},{"key":"2140_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1210\/jcem-45-4-788","volume":"45","author":"JE Seabold","year":"1977","unstructured":"Seabold JE, Haynie TP, Deasis DN, Samaan NA, Glenn HJ, Jahns MF (1977) Detection of metastatic adrenal carcinoma using 131I\u20136-beta-iodomethyl-19-norcholesterol total body scans. J Clin Endocrinol Metab 45:788\u2013797. https:\/\/doi.org\/10.1210\/jcem-45-4-788","journal-title":"J Clin Endocrinol Metab"},{"key":"2140_CR21","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1002\/1097-0142(19931201)72:11<3296::AID-CNCR2820721127>3.0.CO;2-4","volume":"72","author":"E Tartour","year":"1993","unstructured":"Tartour E, Caillou B, Tenenbaum F, Schr\u00f6der S, Luciani S, Talbot M, Schlumberger M (1993) Immunohistochemical study of adrenocortical carcinoma. Predictive value of the D11 monoclonal antibody. Cancer 72:3296\u20133303. https:\/\/doi.org\/10.1002\/1097-0142(19931201)72:11%3c3296::AID-CNCR2820721127%3e3.0.CO;2-4","journal-title":"Cancer"},{"key":"2140_CR22","first-page":"1039","volume":"25","author":"Y Kubota","year":"1997","unstructured":"Kubota Y, Iwai T, Nakatani K, Sakai N, Hara A (1997) Central nervous system metastasis from non-functioning adrenocortical carcinoma: report of a case. No Shinkei Geka 25:1039\u20131042","journal-title":"No Shinkei Geka"},{"key":"2140_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00002341-200105000-00012","volume":"17","author":"GB Bartley","year":"2001","unstructured":"Bartley GB, Campbell RJ, Salom\u00e3o DR, Bradley EA, Marsh WR, Bite U (2001) Adrenocortical carcinoma metastatic to the orbit. Ophthalmic Plast Reconstr Surg 17:215\u2013220. https:\/\/doi.org\/10.1097\/00002341-200105000-00012","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2140_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/jjco\/hyl127","volume":"37","author":"S Ohwada","year":"2007","unstructured":"Ohwada S, Izumi M, Kawate S, Hamada K, Toya H, Togo N, Horiguchi J, Koibuchi Y, Takahashi T, Yamada M (2007) Surgical outcome of Stage III and IV adrenocortical carcinoma. Jpn J Clin Oncol 37:108\u2013113. https:\/\/doi.org\/10.1093\/jjco\/hyl127","journal-title":"Jpn J Clin Oncol"},{"key":"2140_CR25","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jocn.2008.10.013","volume":"16","author":"G Capone","year":"2009","unstructured":"Capone G, Della Pepa GM, Sabatino G, Bartoccioni E, Albanese A, Mannino S, Maira G (2009) A rare bone\u2013leptomeningeal metastasis from an adrenal cortical carcinoma. J Clin Neurosci 16:977\u2013980. https:\/\/doi.org\/10.1016\/j.jocn.2008.10.013","journal-title":"J Clin Neurosci"},{"key":"2140_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1210\/jc.2014-2650","volume":"100","author":"M Burotto","year":"2015","unstructured":"Burotto M, Tageja N, Rosenberg A, Mahalingam S, Quezado M, Velarde M, Edgerly M, Fojo T (2015) Brain metastasis in patients with adrenocortical carcinoma: a clinical series. J Clin Endocrinol Metab 100:331\u2013336. https:\/\/doi.org\/10.1210\/jc.2014-2650","journal-title":"J Clin Endocrinol Metab"},{"key":"2140_CR27","doi-asserted-by":"publisher","unstructured":"Lefevre M, Gerard-Marchant R, Gubler JP, Chaussain JL, Lemerle J (1983) Adrenal cortical carcinoma in children: 42 patients treated from 1958 to 1980 at Villejuif. In: Humphrey GB, Grindey GB, Dehner LP, Acton RT, Pysher TJ (eds) Adrenal and endocrine tumors in children. Cancer treatment and research, vol 17. Springer, Boston, MA. https:\/\/doi.org\/10.1007\/978-1-4613-3891-8_11","DOI":"10.1007\/978-1-4613-3891-8_11"},{"key":"2140_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/1097-0142(19880801)62:3<507::AID-CNCR2820620311>3.0.CO;2-8","volume":"62","author":"S Saracco","year":"1988","unstructured":"Saracco S, Abramowsky C, Taylor S, Silverman RA, Berman BW (1988) Spontaneously regressing adrenocortical carcinoma in a newborn. A case report with dna ploidy analysis. Cancer 62:507\u2013511. https:\/\/doi.org\/10.1002\/1097-0142(19880801)62:3%3c507::AID-CNCR2820620311%3e3.0.CO;2-8","journal-title":"Cancer"},{"key":"2140_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/00043426-199124000-00013","volume":"13","author":"M Ayass","year":"1991","unstructured":"Ayass M, Gross S, Harper J (1991) High-dose carboplatinum and vp-16 in treatment of metastatic adrenal carcinoma. J Pediatr Hematol Oncol 13:470\u2013472. https:\/\/doi.org\/10.1097\/00043426-199124000-00013","journal-title":"J Pediatr Hematol Oncol"},{"key":"2140_CR30","first-page":"1","volume":"27 Pt 1","author":"EE Lack","year":"1992","unstructured":"Lack EE, Mulvihill JJ, Travis WD, Kozakewich HP (1992) Adrenal cortical neoplasms in the pediatric and adolescent age group. Clinicopathologic study of 30 cases with emphasis on epidemiological and prognostic factors. Pathol Annu 27 Pt 1:1\u201353","journal-title":"Pathol Annu"},{"key":"2140_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00041327-200020010-00012","volume":"20","author":"AM Piniella","year":"2000","unstructured":"Piniella AM, Siatkowski MR (2000) Adrenal Cortical Carcinoma Metastatic to the Brain in a Child. J Neuroophthalmol 20:35\u201337. https:\/\/doi.org\/10.1097\/00041327-200020010-00012","journal-title":"J Neuroophthalmol"},{"key":"2140_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0303-8467(01)00105-6","volume":"103","author":"RL Romaguera","year":"2001","unstructured":"Romaguera RL, Minagar A, Bruce JH, Jagid JR, Falcone S, Curless RG, Ragheb J, Morrison G (2001) Adrenocortical carcinoma with cerebral metastasis in a child: case report and review of the literature. Clin Neurol Neurosurg 103:46\u201350. https:\/\/doi.org\/10.1016\/S0303-8467(01)00105-6","journal-title":"Clin Neurol Neurosurg"},{"key":"2140_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1651-2227.2003.tb00575.x","volume":"92","author":"N Hertel","year":"2007","unstructured":"Hertel N, Carlsen N, Kerndrup G, Pedersen I, Clausen N, Hahnemann J, Jacobsen B (2007) Late relapse of adrenocortical carcinoma in Beckwith-Wiedemann syndrome. Clinical, endocrinological and genetic aspects. Acta Paediatr 92:439\u2013443. https:\/\/doi.org\/10.1111\/j.1651-2227.2003.tb00575.x","journal-title":"Acta Paediatr"},{"key":"2140_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11060-005-0376-z","volume":"75","author":"AS Wagner","year":"2005","unstructured":"Wagner AS, Fleitz JM, Kleinschmidt-DeMasters BK (2005) Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature. J Neurooncol 75:127\u2013133. https:\/\/doi.org\/10.1007\/s11060-005-0376-z","journal-title":"J Neurooncol"},{"key":"2140_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12672-022-00486-1","volume":"13","author":"Rv Steenaard","year":"2022","unstructured":"Steenaard Rv, RutjensEttaieb MHTvan NoeselHaak MMHTMMHR (2022) EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity. Discover Oncology 13:25. https:\/\/doi.org\/10.1007\/s12672-022-00486-1","journal-title":"Discover Oncology"},{"key":"2140_CR36","doi-asserted-by":"publisher","first-page":"a037242","DOI":"10.1101\/cshperspect.a037242","volume":"10","author":"AE Yuzhalin","year":"2020","unstructured":"Yuzhalin AE, Yu D (2020) Brain METASTASIS ORGANOTROPISM. Cold Spring Harb Perspect Med 10:a037242. https:\/\/doi.org\/10.1101\/cshperspect.a037242","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2140_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10072-014-1881-7","volume":"36","author":"MG Passarin","year":"2015","unstructured":"Passarin MG, Sava T, Furlanetto J, Molino A, Nortilli R, Musso AM, Zaninelli M, Franceschi T, Orrico D, Marangoni S, Dealis C, Graiff C, Filippo R, Grisanti S, Simoncini E, Vassalli L, Berruti A, Pedersini R (2015) Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. Neurol Sci 36:117\u2013123. https:\/\/doi.org\/10.1007\/s10072-014-1881-7","journal-title":"Neurol Sci"},{"key":"2140_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11060-020-03598-2","volume":"151","author":"KM Hotchkiss","year":"2021","unstructured":"Hotchkiss KM, Sampson JH (2021) Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor. J Neurooncol 151:55\u201362. https:\/\/doi.org\/10.1007\/s11060-020-03598-2","journal-title":"J Neurooncol"},{"issue":"555\u201360","key":"2140_CR39","first-page":"569","volume":"32","author":"KC Schreck","year":"2018","unstructured":"Schreck KC, Grossman SA (2018) Role of temozolomide in the treatment of cancers involving the central nervous system. Oncology (Williston Park) 32(555\u201360):569","journal-title":"Oncology (Williston Park)"},{"key":"2140_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.674039","author":"D Cosentini","year":"2021","unstructured":"Cosentini D, Turla A, Carminati O, Grisanti S, Ferrari VD, Lagan\u00e0 M, Rosti G, Sigala S, Berruti A (2021) Case report: exceptional response to second line temozolomide therapy in a patient with metastatic adrenocortical carcinoma. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.674039","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2140_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1530\/EJE-19-0570","volume":"181","author":"D Cosentini","year":"2019","unstructured":"Cosentini D, Badalamenti G, Grisanti S, Basile V, Rapa I, Cerri S, Spallanzani A, Perotti P, Musso E, Lagan\u00e0 M, Ferrari VD, Luppi G, Dalla Volta A, Incorvaia L, Sigala S, Russo A, Volante M, Terzolo M, Berruti A (2019) Activity and safety of temozolomide in advanced adrenocortical carcinoma patients. Eur J Endocrinol 181:681\u2013689. https:\/\/doi.org\/10.1530\/EJE-19-0570","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02140-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02140-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02140-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T19:14:14Z","timestamp":1704827654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02140-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["2140"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02140-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"2 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alfredo Berruti received fees for public speech from HRA Pharma and received research funds for research in adrenocortical carcinoma by Janssen and Sanofi. Sandra Sigala received funds for preclinical research in adrenocortical carcinoma from Novartis and Pharmamar. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The four adult patients followed at Spedali Civili of Brescia were included in the ENSAT registry (), approved by the Ethical Review Board of ASST-Spedali Civili in Brescia, and were treated in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent was obtained from each patient for the recording of pseudonymized and standardized data, including images, in the ENSAT registry for use in any current and future adrenal tumor-related projects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the procedures being performed were part of the routine care.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}